Clinical Trial Update: Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing telmisartan with the combination of losartan and hydrochlorothiazide in adults with mild-to-moderate essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Losartan/Hydrochlorothiazide (losartan/hydrochlorothiazide)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED